Cover Image
市場調查報告書

全球動物用寄生蟲驅除劑市場趨勢與預測:病原生物·產品·動物物種·各地區

Global Veterinary Paraciticides Market - segmented by disease causing organisms, By products, By animal types & by Geography - Trends & Forecasts 2016- 2021.

出版商 Mordor Intelligence LLP 商品編碼 319397
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球動物用寄生蟲驅除劑市場趨勢與預測:病原生物·產品·動物物種·各地區 Global Veterinary Paraciticides Market - segmented by disease causing organisms, By products, By animal types & by Geography - Trends & Forecasts 2016- 2021.
出版日期: 2016年08月01日 內容資訊: 英文 190 Pages
簡介

全球動物用寄生蟲驅除劑市場預測從2014年到2020年間將以6.0%的年複合成長率擴大,市值從2014年的289億美元到2020年將達到397億美元。

本報告提供全球動物用寄生蟲驅除劑市場相關資料,提供您包含病原生物,產品,動物物種及地區別相關調查分析,彙整市場現狀及未來的預測,全面競爭情形分析,及主要企業的市場佔有率和近幾年的發展趨勢等詳細資訊。

第1章 簡介

第2章 市場分析

  • 市售的動物藥
  • 獸醫學vs.人類醫學

第3章 市場動態

  • 推動市場的要素
  • 市場抑制因素
  • 波特的五力分析

第4章 全球動物用寄生蟲驅除劑市場區隔

  • 全球動物用寄生蟲驅除劑市場:病原生物別
    • 簡介
    • 外部寄生蟲驅除劑
      • 跳蚤
      • 蝨子
      • 扁虱
    • 內部寄生蟲驅除劑
      • 腸胃管線蟲
      • 狗線狀蟲
      • 肺線蟲
  • 全球動物用寄生蟲驅除劑市場:各產品
    • 口服液
    • 藥錠
    • 注射劑
    • 噴霧
    • 淋劑
    • 滴劑
    • 項圈
    • 耳標
  • 全球動物用寄生蟲驅除劑市場:各類型
    • 寵物
    • 家畜
      • 綿羊
  • 全球動物用寄生蟲驅除劑市場:各地區
    • 北美
    • 歐洲
    • 亞太地區

第5章 競爭情形

  • 市場主要企業
  • M&A
  • 新產品銷售
  • 協定,合作及合作

第6章 企業簡介

  • Zoetis animal healthcare
    • 財務概要
    • 產業概要
    • 產業策略
  • Merck
  • Merial (Sanofi的動物保健部門)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global veterinary parasiticides market was valued at USD 2,714 million in 2014 and is projected to reach USD 5,121million by 2020, at a CAGR of 11.16% during the forecast period from 2014 to 2019.

Global Veterinary Parasiticides Market- Market Dynamics

Veterinary pharmaceuticals, including parasiticides, have transformed the health of companion and livestock animals across the globe over the past two decades. Today, the spectrum of parasiticides for veterinary applications continues to expand with a variety of ectoparasiticides, endoparasiticides, and endectocides that are launched every year. Constant innovations are leading to the emergence of novel parasiticide delivery systems as well in this market.

Drivers

Some of the key factors driving the market towards growth are:

  • Increase in pet ownership
  • Improved nutrition
  • Intensifying consumer focus on food safety
  • Greater livestock production rates
  • Increasing food-borne diseases

Restraints

Some of the factors restraining the market are:

  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Increased competition for cost-effective production

The global veterinary parasiticides market can be segmented on the basis of disease-causing organisms into Ectoparasiticides (fleas, lice, mites) and Endoparasiticides (gastrointestinal nematode, heartworms, lungworms). By products, the market can be segmented into oral liquids, tablets, injectables, sprays, pour on, spot on, collars, and ear tags. By species, the market can be further classified into companion animals (dogs, cats, horses, and others) and farm animals (cattle, swine, poultry, fish, and sheep). Lastly, by geography, the market can be divided into North America (US, Canada, Mexico), Europe (France, Italy, Germany, Spain, Sweden, Rest of Europe), and Asia-Pacific (China, Japan, India, Rest of Asia-Pacific).

Some of the key players in the market are:

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health, Inc.
  • Elanco
  • Merck
  • Merial (Animal Health Division of Sanofi)

Key Deliverables in the Study

  • Market analysis for the veterinary parasiticides market, with region specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the veterinary parasiticides market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

Table of Contents

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs. human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.3.3. Cost-effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4.Global veterinary parasiticides market Segmentation

  • 4.1. Global veterinary Parasiticides Market, By disease causing organisms
    • 4.1.1. Introduction
    • 4.1.2. Ectoparasiticides
      • 4.1.2.1. Fleas
      • 4.1.2.1. Lice
      • 4.1.2.1. Mites
    • 4.1.3. Endoparasiticides
      • 4.1.3.1. Gastrointestinal nematode
      • 4.1.3.2. Heartworms
      • 4.1.3.3. Lungworms
  • 4.2. Global veterinary Parasiticides Market, By products
    • 4.2.1. Oral Liquids
    • 4.2.2. Tablets
    • 4.2.3. Injectables
    • 4.2.4. Sprays
    • 4.2.5. Pour On
    • 4.2.6. Spot On
    • 4.2.7. Collars
    • 4.2.8. Ear Tags
  • 4.3. Global veterinary Parasiticides Market, By species
    • 4.3.1. Companion Animals
      • 4.3.1.1. Dogs
      • 4.3.1.2. Cats
      • 4.3.1.3. Horses
    • 4.3.2. Farm animal
      • 4.3.2.1. Cattle
      • 4.3.2.2. Swine
      • 4.3.2.3. Poultry
      • 4.3.2.4. Fish
      • 4.3.2.5. Sheep
  • 4.4. .Global Veterinary Market Segmentation, By Geography
    • 4.4.1. North America
      • 4.4.1.1. US
      • 4.4.1.2. Mexico
      • 4.4.1.3. Canada
    • 4.4.2. Europe
      • 4.4.2.1. France
      • 4.4.2.2. Italy
      • 4.4.2.3. Germany
      • 4.4.2.4. Spain
      • 4.4.2.5. Sweden
      • 4.4.2.6. Rest of Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. India
      • 4.4.3.2. China
      • 4.4.3.3. Japan
      • 4.4.3.4. Rest of Asia-Pacific

5. Competitive landscape

  • 5.1. Major players in the market
  • 5.2. Mergers and acquisitions
  • 5.3. New product launches
  • 5.4. Agreement, Collaborations, and Partnerships
  • 5.5. Recommendations for New players in the market
  • 5.6. Recommendations for Existing players in the market

6. Company profiles

  • 6.1. Zoetis animal healthcare
    • 6.1.1. Financial Overview
    • 6.1.2. Business overview
    • 6.1.3. Business strategies
  • 6.2. Merck
    • 6.2.1. Financial Overview
    • 6.2.2. Business overview
    • 6.2.3. Business strategies
  • 6.3. Merial (Animal Health Division Of Sanofi)
    • 6.3.1. Financial Overview
    • 6.3.2. Business overview
    • 6.3.3. Business strategies
  • 6.4. Elanco
    • 6.4.1. Financial Overview
    • 6.4.2. Business overview
    • 6.4.3. Business strategies
  • 6.5. Bayer healthcare
    • 6.5.1. Financial Overview
    • 6.5.2. Business overview
    • 6.5.3. Business strategies
  • 6.6. Ceva Animal Health, Inc.
    • 6.6.1. Financial Overview
    • 6.6.2. Business overview
    • 6.6.3. Business strategies
  • 6.7. Virbac
    • 6.7.1. Financial Overview
    • 6.7.2. Business overview
    • 6.7.3. Business strategies
  • 6.8. Boehringer Ingelheim
    • 6.8.1. Financial Overview
    • 6.8.2. Business overview
    • 6.8.3. Business strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top